Incidence, prevalence, and pattern of medical service utilization of children's rare lung diseases in South Korea
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Kim, Hwan Soo | - |
dc.contributor.author | Choi, Jiin | - |
dc.contributor.author | Lee, Eun | - |
dc.contributor.author | Park, Ji Soo | - |
dc.contributor.author | Jung, Sungsu | - |
dc.contributor.author | Yoon, Jisun | - |
dc.contributor.author | Lee, Kyeong Hun | - |
dc.contributor.author | Kim, Kyunghoon | - |
dc.contributor.author | Yang, Hyeon-Jong | - |
dc.contributor.author | Suh, Dong In | - |
dc.date.accessioned | 2024-06-12T02:30:42Z | - |
dc.date.available | 2024-06-12T02:30:42Z | - |
dc.date.issued | 2024-02 | - |
dc.identifier.issn | 8755-6863 | - |
dc.identifier.issn | 1099-0496 | - |
dc.identifier.uri | https://scholarworks.bwise.kr/sch/handle/2021.sw.sch/26385 | - |
dc.description.abstract | IntroductionChildren's rare lung diseases are a heterogeneous group of rare lung diseases with significant morbidity and mortality. There is very limited information on the incidence and prevalence of children's rare lung diseases in Asia. We investigated the nationwide incidence, prevalence, and pattern of medical service utilization of children's rare lung diseases in Korea.MethodsWe studied patients who were diagnosed with rare lung diseases coded per International Statistical Classification of Diseases and Related Health Problems, 10th Edition and registered in the national rare diseases database of confirmed patients. Data was extracted from the Korean National Health Insurance Service Claims database over 2019-2021.ResultsAverage incidence rate was 12.9 new cases per million children per year, and average prevalence rate was 60.2 cases per million children during the study period of 2019-2021. We found that more than 65% of new cases were diagnosed before 2 years of age. ChILD, primary ciliary dyskinesia, and cystic fibrosis were usually diagnosed after 6 years of age. Congenital airway and lung anomalies were often diagnosed before 2 years of age. Busan and Gyeongsangnam-do residents tended to visit hospitals near their place of residence, while residents of other areas tended to visit hospitals in Seoul regardless of their area of residence.ConclusionsWe examined the epidemiology of rare lung diseases in children in South Korea. Our estimation of the incidence and prevalence could be used for sustainable health care and equitable distribution of health care resources. | - |
dc.language | 영어 | - |
dc.language.iso | ENG | - |
dc.publisher | WILEY | - |
dc.title | Incidence, prevalence, and pattern of medical service utilization of children's rare lung diseases in South Korea | - |
dc.type | Article | - |
dc.publisher.location | 미국 | - |
dc.identifier.doi | 10.1002/ppul.26906 | - |
dc.identifier.scopusid | 2-s2.0-85185671244 | - |
dc.identifier.wosid | 001168817900001 | - |
dc.identifier.bibliographicCitation | PEDIATRIC PULMONOLOGY | - |
dc.citation.title | PEDIATRIC PULMONOLOGY | - |
dc.type.docType | Article; Early Access | - |
dc.description.isOpenAccess | N | - |
dc.description.journalRegisteredClass | scie | - |
dc.description.journalRegisteredClass | scopus | - |
dc.relation.journalResearchArea | Pediatrics | - |
dc.relation.journalResearchArea | Respiratory System | - |
dc.relation.journalWebOfScienceCategory | Pediatrics | - |
dc.relation.journalWebOfScienceCategory | Respiratory System | - |
dc.subject.keywordAuthor | children | - |
dc.subject.keywordAuthor | epidemiology | - |
dc.subject.keywordAuthor | National Health Insurance Service Claims | - |
dc.subject.keywordAuthor | rare lung disease | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
(31538) 22, Soonchunhyang-ro, Asan-si, Chungcheongnam-do, Republic of Korea+82-41-530-1114
COPYRIGHT 2021 by SOONCHUNHYANG UNIVERSITY ALL RIGHTS RESERVED.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.